AZoRobotics on MSN2 小时
Lumea, AIRA Matrix, and Acupath Join Forces to Advance AI-Based Bladder Cancer Diagnosis
Lumea, a leader in digital pathology solutions. AIRA Matrix Private Limited, an innovative technology company for AI-based ...
Fulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A Buy
Fulgent Genetics has a low Price/Book ratio and promising drug candidates. Key trial results are expected in May 2025. Read ...